Halo Labs

company

About

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$6.99M
Industries
Analytics,Biopharma,Biotechnology,Health Diagnostics,Pharmaceutical
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics.

Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.

The company was founded in 2011 and headquartered in Pennsylvania, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$8.27M
Halo Labs has raised a total of $8.27M in funding over 2 rounds. Their latest funding was raised on Jul 11, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 11, 2022 Series C $6.99M 1 Agilent Technologies Detail
Mar 12, 2012 Grant $1.27M 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Halo Labs is funded by 2 investors. Agilent Technologies and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Agilent Technologies Yes Series C
National Science Foundation Yes Grant